Meta Pixel

News and Announcements

First Graphene (ASX: FGR) Applies for NICNAS Listing of PureGRAPHTM

  • Published February 12, 2019 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • First Graphene has applied to have PureGRAPHTM graphene notified and assessed by The National Industrial Chemicals Notification and Assessment Scheme (NICNAS) for listing on the Australian Inventory of Chemical Substances (AICS).
  • Assessment and the issuing of a certificate from NICNAS enables sales of PureGRAPHTM in Australia.
  • Comprehensive REACH registration dossier greatly facilitated the product submission in Australia.

Advanced materials company, First Graphene Limited (“FGR” or “the Company”) (ASX: FGR) is pleased to announce it has applied to have PureGRAPHTM graphene notified and assessed by The National Industrial Chemicals Notification and Assessment Scheme (NICNAS) for listing on the Australian Inventory of Chemical Substances (AICS).

It is necessary for all producers, or potential producers, of graphene to complete the NICNAS application for the CAS number of graphene. FGR has worked closely with its consultants to submit a comprehensive application. This has involved providing items such as chemical characterisation, toxicology and environmental information, all of which required considerable research. An advantage of being a first mover is that once the new chemical is approved, it is kept confidential (not on the
public or confidential inventory lists) for the first 5 years – this is called the ‘non-listing period’ and means First Graphene can import or manufacture the new chemical under this registration. The Company is now registered for REACH following its recent application for its PureGRAPHTM graphene products in Europe.

To the best of the Company’s knowledge FGR is the first graphene entity in Australia to make application to NICNAS for the for listing on AICS of graphene as a new nano-material.

Craig McGuckin, Managing Director said “This is another important step forward in the growth of our graphene materials business in Australia. In conjunction with FGR’s recent REACH registration it demonstrates our position as the leading ethical supplier of tonnage quantities of high- quality graphene products.”

Register Interest

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now